FDA Allergenic Products Advisory Committee Votes to Support the Use of Aimmune ’s Palforzia (AR101) for Peanut Allergy

BRISBANE, Calif.--(BUSINESS WIRE)--Sep. 13, 2019-- Aimmune Therapeutics, Inc. (Nasdaq:AIMT), a biopharmaceutical company developing treatments for potentially life-threatening food allergies, today announced that the Allergenic Products Advisory...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news